A Human Dectin-2 Deficiency Associated with Invasive Aspergillosis

James S. Griffiths, P. Lewis White, Magdalena A. Czubala, Elena Simonazzi, Mariolina Bruno, Aiysha Thompson, Pierre J. Rizkallah, Mark Gurney, Diogo M. Da Fonseca, Julian R. Naglik, Wendy Ingram, Keith Wilson, Frank L. Van De Veerdonk, Rosemary Barnes, Philip R. Taylor, Selinda J. Orr*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

Immunocompromised patients are highly susceptible to invasive aspergillosis. Herein, we identified a homozygous deletion mutation (507 del C) resulting in a frameshift (N170I) and early stop codon in the fungal binding Dectin-2 receptor, in an immunocompromised patient. The mutated form of Dectin-2 was weakly expressed, did not form clusters at/near the cell surface and was functionally defective. Peripheral blood mononuclear cells from this patient were unable to mount a cytokine (tumor necrosis factor, interleukin 6) response to Aspergillus fumigatus, and this first identified Dectin-2-deficient patient died of complications of invasive aspergillosis.

Original languageEnglish
Pages (from-to)1219-1224
Number of pages6
JournalJournal of Infectious Diseases
Volume224
Issue number7
DOIs
Publication statusPublished - 1 Oct 2021

Keywords

  • Aspergillus
  • Candida
  • CLR
  • Dectin-2
  • fungal immunology
  • host-pathogen interactions
  • inflammation
  • innate immunity

Fingerprint

Dive into the research topics of 'A Human Dectin-2 Deficiency Associated with Invasive Aspergillosis'. Together they form a unique fingerprint.

Cite this